Abstract

Somatic mutations in the spliceosome gene ZRSR2 — located on the X chromosome — are associated with myelodysplastic syndrome (MDS). ZRSR2 is involved in the recognition of 3΄ splice site during the early stages of spliceosome assembly; however, its precise role in RNA splicing has remained unclear. Here, we characterize ZRSR2 as an essential component of the minor spliceosome (U12-dependent) assembly. shRNA mediated knockdown of ZRSR2 leads to impaired splicing of the U12-type introns, and RNA-Sequencing of MDS bone marrow reveals that loss of ZRSR2 activity causes increased mis-splicing. These splicing defects involve retention of the U12-type introns while splicing of the U2-type introns remain mostly unaffected. ZRSR2 deficient cells also exhibit reduced proliferation potential and distinct alterations in myeloid and erythroid differentiation in vitro. These data identify a specific role for ZRSR2 in RNA splicing and highlight dysregulated splicing of U12-type introns as a characteristic feature of ZRSR2 mutations in MDS.

Highlights

  • Somatic mutations in the spliceosome gene ZRSR2—located on the X chromosome—are associated with myelodysplastic syndrome (MDS)

  • In MDS, somatic mutations in ZRSR2 occur across the entire length of the transcript, which is in contrast to mutational hotspots observed in SF3B1, SRSF2 and U2AF1

  • In a previous study, ectopic expression of mutant U2AF1—a splice factor related to ZRSR2 and frequently mutated in MDS—results in higher frequency of exon skipping from GH1 minigene construct[12]

Read more

Summary

Introduction

Somatic mutations in the spliceosome gene ZRSR2—located on the X chromosome—are associated with myelodysplastic syndrome (MDS). ShRNA-mediated knockdown of ZRSR2 leads to impaired splicing of the U12-type introns and RNA-sequencing of MDS bone marrow reveals that loss of ZRSR2 activity causes increased mis-splicing. These splicing defects involve retention of the U12-type introns, while splicing of the U2-type introns remain mostly unaffected. ZRSR2-deficient cells exhibit reduced proliferation potential and distinct alterations in myeloid and erythroid differentiation in vitro These data identify a specific role for ZRSR2 in RNA splicing and highlight dysregulated splicing of U12-type introns as a characteristic feature of ZRSR2 mutations in MDS. This study uncovers a specific function of ZRSR2 in RNA splicing and suggests its role in haematopoietic development

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.